THTX - Theratechnologies

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Theratechnologies beats top-line and bottom-line estimates; initiates FY24 outlook
• Annovis Bio, Kura Oncology among other healthcare movers
• Theratechnologies says FDA rejected new Egrifta version
• Omeros, Aspira Women's Health among healthcare movers
• Theratechnologies stock slides as Egrifta review runs beyond FDA target date
• Upcoming FDA Decision: How likely is approval for EGRIFTA MDV?
• Theratechnologies files for $100M mixed securities shelf
• Theratechnologies announces FDA nod of Trogarzo 90-second intravenous push loading dose
• Theratechnologies prices its public offering; shares plummet
• Theratechnologies proposes stock offering, private placement
• Theratechnologies says Trogarzo IM method of administration study did not meet primary endpoint
• Theratechnologies reports Q3 results
• Theratechnologies completes 1-for-4 reverse stock split
• Theratechnologies amends credit facility terms to lower minimum liquidity
• Theratechnologies announces 1-for-4 reverse stock split
• Theratechnologies reports Q2 results
• Theratechnologies GAAP EPS of -$0.11 misses by $0.06, revenue of $19.9M misses by $1.3M
• Nasdaq notifies Theratechnologies regarding share price noncompliance
• Theratechnologies reports Q4 earnings miss; initiates FY23 outlook
• Theratechnologies slumps 30% as cancer drug trial enrollment paused on efficacy, safety woes